Renal Cancers Completed Phase 1 Trials for Bortezomib (DB00188)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00620295Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsTreatment
NCT00622674Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsTreatment